Efficacy of Transdermal Fentanyl Patches in Relief of Acute Postoperative Pain After Mastectomy

South Egypt Cancer Institute1 site in 1 country60 target enrollmentFebruary 2, 2017

ConditionsBreast Cancer Female

InterventionsThe Transdermal Therapeutic System-Fentanyl (TTS-F)Intravenous patient-controlled analgesia (PCA) morphine

DrugsThe Transdermal Therapeutic System-Fentanyl (TTS-F)

Overview

Phase: Phase 4
Intervention: The Transdermal Therapeutic System-Fentanyl (TTS-F)
Conditions: Breast Cancer Female
Sponsor: South Egypt Cancer Institute
Enrollment: 60
Locations: 1
Primary Endpoint: Total dose of morphine consumption in the first 48 hours postoperative
Last Updated: 9 years ago

Overview Investigators Eligibility Criteria Arms & Interventions Outcomes Sites Similar Trials

Overview

Brief Summary

to determine the safety, efficacy and tolerability of transdermal fentanyl in patients undergoing mastectomy, as well as the postoperative consumption of analgesic.

Registry

clinicaltrials.gov

Start Date

February 2, 2017

End Date

April 2017

Last Updated

9 years ago

Study Type

Interventional

Study Design

Parallel

Sex

Female

Investigators

Sponsor

South Egypt Cancer Institute

Responsible Party

Principal Investigator

Dr.mohamad farouk mohamad

lecturer of anesthesia and pain relief

South Egypt Cancer Institute

Eligibility Criteria

Inclusion Criteria

•ASA I - II patients
•aged 30-60 years
•body weight ranged between 65-10kg

Exclusion Criteria

•Patients with history of allergy to morphine
•chronic intake of analgesics or non-steroidal anti-inflammatory drug 24 h prior to surgery,
•there was a history of a psychiatric disorder patients weight was less then 50kg.
•impaired kidney function.